Tiffany Weinkopff
Concepts (128)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leishmaniasis, Cutaneous | 5 | 2023 | 14 | 3.330 |
Why?
| Leishmania major | 4 | 2022 | 9 | 2.350 |
Why?
| Macrophages | 5 | 2023 | 364 | 1.500 |
Why?
| Lymphangiogenesis | 2 | 2021 | 3 | 1.350 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2019 | 201 | 1.170 |
Why?
| Leishmania braziliensis | 3 | 2015 | 3 | 1.040 |
Why?
| Leishmania | 2 | 2023 | 5 | 1.020 |
Why?
| Signal Transduction | 4 | 2021 | 1617 | 0.950 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2021 | 2 | 0.900 |
Why?
| Antigens, Helminth | 3 | 2014 | 4 | 0.860 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 40 | 0.760 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 56 | 0.680 |
Why?
| Elephantiasis, Filarial | 3 | 2014 | 3 | 0.680 |
Why?
| Mice | 11 | 2023 | 5720 | 0.560 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 32 | 0.560 |
Why?
| Cytokines | 3 | 2014 | 612 | 0.550 |
Why?
| Lymphatic Vessels | 2 | 2016 | 46 | 0.510 |
Why?
| Animals | 14 | 2023 | 13150 | 0.510 |
Why?
| Endothelial Cells | 4 | 2022 | 269 | 0.510 |
Why?
| Wuchereria bancrofti | 1 | 2014 | 1 | 0.490 |
Why?
| Psychodidae | 1 | 2014 | 2 | 0.470 |
Why?
| Host-Parasite Interactions | 1 | 2014 | 16 | 0.470 |
Why?
| Saliva | 1 | 2014 | 54 | 0.460 |
Why?
| Monocytes | 1 | 2014 | 132 | 0.460 |
Why?
| Toll-Like Receptor 9 | 1 | 2013 | 10 | 0.440 |
Why?
| Eukaryotic Initiation Factor-2 | 2 | 2023 | 18 | 0.430 |
Why?
| Brugia malayi | 1 | 2011 | 1 | 0.400 |
Why?
| Mice, Inbred C57BL | 6 | 2021 | 1806 | 0.380 |
Why?
| Brugia pahangi | 1 | 2009 | 1 | 0.360 |
Why?
| Helminth Proteins | 1 | 2009 | 2 | 0.350 |
Why?
| Endothelium, Vascular | 1 | 2011 | 254 | 0.350 |
Why?
| Skin | 2 | 2023 | 407 | 0.310 |
Why?
| Cells, Cultured | 3 | 2019 | 1571 | 0.300 |
Why?
| Th1 Cells | 2 | 2015 | 51 | 0.240 |
Why?
| Gene Expression Profiling | 2 | 2022 | 1031 | 0.230 |
Why?
| Transcriptome | 2 | 2022 | 313 | 0.210 |
Why?
| I-kappa B Kinase | 1 | 2021 | 20 | 0.200 |
Why?
| Disease Susceptibility | 1 | 2021 | 89 | 0.190 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2021 | 6 | 0.190 |
Why?
| Orthoreovirus, Mammalian | 1 | 2021 | 17 | 0.190 |
Why?
| Gerbillinae | 2 | 2011 | 9 | 0.190 |
Why?
| Interferon Type I | 1 | 2021 | 25 | 0.190 |
Why?
| Reoviridae Infections | 1 | 2021 | 21 | 0.190 |
Why?
| B-Lymphocytes | 1 | 2021 | 170 | 0.190 |
Why?
| Viral Nonstructural Proteins | 1 | 2021 | 56 | 0.180 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 129 | 0.180 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2021 | 163 | 0.170 |
Why?
| Lymph Nodes | 1 | 2021 | 264 | 0.170 |
Why?
| Antigens, CD | 1 | 2019 | 215 | 0.160 |
Why?
| Hypothalamus | 1 | 2018 | 44 | 0.160 |
Why?
| Vagina | 1 | 2018 | 45 | 0.160 |
Why?
| Gastrointestinal Tract | 1 | 2018 | 103 | 0.150 |
Why?
| Parasite Load | 1 | 2016 | 1 | 0.140 |
Why?
| Mice, Inbred BALB C | 2 | 2015 | 303 | 0.140 |
Why?
| Dermis | 1 | 2016 | 17 | 0.140 |
Why?
| Stress, Psychological | 1 | 2018 | 260 | 0.140 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 181 | 0.140 |
Why?
| Antibodies | 1 | 2016 | 155 | 0.130 |
Why?
| Hypersensitivity, Delayed | 1 | 2015 | 21 | 0.130 |
Why?
| NF-kappa B | 2 | 2021 | 314 | 0.130 |
Why?
| Th17 Cells | 1 | 2015 | 26 | 0.130 |
Why?
| Neutrophil Activation | 1 | 2015 | 9 | 0.130 |
Why?
| Humans | 8 | 2023 | 49827 | 0.120 |
Why?
| Gene Expression Regulation | 1 | 2019 | 979 | 0.120 |
Why?
| Cell Movement | 1 | 2015 | 247 | 0.120 |
Why?
| Brazil | 1 | 2014 | 34 | 0.120 |
Why?
| Interferons | 1 | 2014 | 40 | 0.120 |
Why?
| Antibodies, Helminth | 2 | 2011 | 4 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2014 | 116 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 181 | 0.110 |
Why?
| Female | 6 | 2021 | 26329 | 0.110 |
Why?
| Immunoassay | 1 | 2011 | 20 | 0.100 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 104 | 0.090 |
Why?
| Rotavirus Infections | 1 | 2010 | 6 | 0.090 |
Why?
| Rotavirus | 1 | 2010 | 9 | 0.090 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 37 | 0.090 |
Why?
| Phosphorylation | 1 | 2011 | 536 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 103 | 0.090 |
Why?
| Immunoblotting | 1 | 2009 | 118 | 0.090 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 63 | 0.090 |
Why?
| Apoptosis | 1 | 2015 | 1100 | 0.080 |
Why?
| Flow Cytometry | 1 | 2011 | 470 | 0.080 |
Why?
| Amino Acid Sequence | 1 | 2009 | 587 | 0.080 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 241 | 0.080 |
Why?
| Molecular Sequence Data | 1 | 2009 | 797 | 0.080 |
Why?
| Disease Models, Animal | 1 | 2013 | 1451 | 0.080 |
Why?
| Cell Proliferation | 1 | 2011 | 1007 | 0.070 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2021 | 388 | 0.070 |
Why?
| Proteomics | 1 | 2009 | 328 | 0.070 |
Why?
| Mice, Knockout | 2 | 2021 | 841 | 0.070 |
Why?
| Organogenesis | 1 | 2021 | 2 | 0.050 |
Why?
| I-kappa B Proteins | 1 | 2021 | 16 | 0.050 |
Why?
| Lymphoid Tissue | 1 | 2021 | 22 | 0.050 |
Why?
| Homeostasis | 1 | 2021 | 199 | 0.050 |
Why?
| HEK293 Cells | 1 | 2021 | 222 | 0.050 |
Why?
| Animals, Newborn | 1 | 2021 | 366 | 0.040 |
Why?
| Cell Line | 1 | 2021 | 1002 | 0.040 |
Why?
| Fibroblasts | 1 | 2021 | 343 | 0.040 |
Why?
| Paraventricular Hypothalamic Nucleus | 1 | 2018 | 9 | 0.040 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2018 | 27 | 0.040 |
Why?
| Intestinal Absorption | 1 | 2018 | 57 | 0.040 |
Why?
| Cesarean Section | 1 | 2018 | 187 | 0.040 |
Why?
| Body Weight | 1 | 2018 | 513 | 0.030 |
Why?
| Chemokine CCL21 | 1 | 2015 | 4 | 0.030 |
Why?
| Receptors, CCR7 | 1 | 2015 | 5 | 0.030 |
Why?
| Gene Expression | 1 | 2018 | 608 | 0.030 |
Why?
| Antigens | 1 | 2015 | 41 | 0.030 |
Why?
| Phenotype | 1 | 2018 | 727 | 0.030 |
Why?
| Leukocyte Elastase | 1 | 2015 | 4 | 0.030 |
Why?
| L-Selectin | 1 | 2015 | 7 | 0.030 |
Why?
| Neutrophil Infiltration | 1 | 2015 | 26 | 0.030 |
Why?
| Superoxides | 1 | 2015 | 46 | 0.030 |
Why?
| Neutrophils | 1 | 2015 | 137 | 0.030 |
Why?
| Child, Preschool | 2 | 2011 | 3853 | 0.030 |
Why?
| Diethylcarbamazine | 1 | 2011 | 1 | 0.020 |
Why?
| Haiti | 1 | 2011 | 4 | 0.020 |
Why?
| Ivermectin | 1 | 2011 | 9 | 0.020 |
Why?
| Anthelmintics | 1 | 2011 | 8 | 0.020 |
Why?
| Inflammation | 1 | 2015 | 604 | 0.020 |
Why?
| Immunoglobulin G | 1 | 2011 | 186 | 0.020 |
Why?
| Pregnancy | 1 | 2018 | 2584 | 0.020 |
Why?
| Egypt | 1 | 2010 | 13 | 0.020 |
Why?
| Male | 2 | 2021 | 25093 | 0.020 |
Why?
| Genotype | 1 | 2010 | 538 | 0.020 |
Why?
| Hospitals | 1 | 2010 | 175 | 0.020 |
Why?
| Infant, Newborn | 1 | 2010 | 2744 | 0.010 |
Why?
| Infant | 1 | 2010 | 3551 | 0.010 |
Why?
| Child | 1 | 2011 | 6824 | 0.010 |
Why?
|
|
Weinkopff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|